Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B GOTTLIEB

Showing results (411-420 of 523) with videos related to

Pageof 53
Sort By:
Dermatology and Therapy|December 12, 2022
Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2)Paolo Gisondi, Alice B Gottlieb, Boni Elewski, et al.
Lancet (London, England)|July 13, 2020
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trialDavid Rosmarin, Amit G Pandya, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology|December 14, 2011
The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: results of a prospective, multicenter, open-label studyAlice B Gottlieb, Robert E Kalb, Andrew Blauvelt, et al.
Expert Opinion on Drug Safety|September 5, 2024
Treatment-emergent Candida infections in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis treated with ixekizumab: an integrated safety analysis of 25 clinical studiesSergio Schwartzman, Luis Puig, Arnon D Cohen, et al.
ACR Open Rheumatology|July 30, 2024
Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 StudiesIain B McInnes, Philip J Mease, Yoshiya Tanaka, et al.
Journal of the American Academy of Dermatology|June 22, 2018
Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studiesFarzad Alinaghi, Monika Calov, Lars Erik Kristensen, et al.
BMJ Open|February 22, 2017
Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomesLinnea Thorlacius, John R Ingram, Amit Garg, et al.
Journal of the American Academy of Dermatology|April 10, 2017
Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinibBrooke Rothstein, Deep Joshipura, Ami Saraiya, et al.
Annals of the Rheumatic Diseases|May 10, 2017
Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage studyAlexander Egeberg, Lars Erik Kristensen, Jacob P Thyssen, et al.
The Journal of Clinical Investigation|June 8, 1999
Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactionsF J Ghadessy, J Lim, A A Abdullah, et al.
Pageof 53

Showing results (411-420 of 523) with videos related to

Sort By:
Pageof 53
Dermatology and Therapy|December 12, 2022
Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2)Paolo Gisondi, Alice B Gottlieb, Boni Elewski, et al.
Lancet (London, England)|July 13, 2020
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trialDavid Rosmarin, Amit G Pandya, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology|December 14, 2011
The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: results of a prospective, multicenter, open-label studyAlice B Gottlieb, Robert E Kalb, Andrew Blauvelt, et al.
Expert Opinion on Drug Safety|September 5, 2024
Treatment-emergent Candida infections in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis treated with ixekizumab: an integrated safety analysis of 25 clinical studiesSergio Schwartzman, Luis Puig, Arnon D Cohen, et al.
ACR Open Rheumatology|July 30, 2024
Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 StudiesIain B McInnes, Philip J Mease, Yoshiya Tanaka, et al.
Journal of the American Academy of Dermatology|June 22, 2018
Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studiesFarzad Alinaghi, Monika Calov, Lars Erik Kristensen, et al.
BMJ Open|February 22, 2017
Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomesLinnea Thorlacius, John R Ingram, Amit Garg, et al.
Journal of the American Academy of Dermatology|April 10, 2017
Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinibBrooke Rothstein, Deep Joshipura, Ami Saraiya, et al.
Annals of the Rheumatic Diseases|May 10, 2017
Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage studyAlexander Egeberg, Lars Erik Kristensen, Jacob P Thyssen, et al.
The Journal of Clinical Investigation|June 8, 1999
Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactionsF J Ghadessy, J Lim, A A Abdullah, et al.
Pageof 53